FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder

Core Viewpoint - The FDA has approved leucovorin for treating cerebral folate transport deficiency, a neurological disorder, which the Trump administration previously promoted as a potential therapy for autism [1] Group 1 - The approval of leucovorin marks a significant development in the treatment of cerebral folate transport deficiency [1] - The drug has been associated with potential benefits for autism, although its primary approval is for a different neurological condition [1]